Close Menu

NEW YORK – Roche announced Tuesday that its SARS-CoV-2 rapid antigen test will receive CE marking in late September and will then launch in countries accepting such designation.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.